MYLAN 8008 MYLAN 8008 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint MYLAN 8008 MYLAN 8008 is Purple / White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint: MYLAN 8008 MYLAN 8008
Strength: 125 mg
Color: Purple / White
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.